Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia

被引:154
作者
Vadakekolathu, Jayakumar [1 ]
Minden, Mark D. [2 ]
Hood, Tressa [3 ]
Church, Sarah E. [3 ]
Reeder, Stephen [1 ]
Altmann, Heidi [4 ]
Sullivan, Amy H. [3 ]
Viboch, Elena J. [3 ]
Patel, Tasleema [5 ,6 ,7 ]
Ibrahimova, Narmin [2 ]
Warren, Sarah E. [3 ]
Arruda, Andrea [2 ]
Liang, Yan [3 ]
Smith, Thomas H. [3 ]
Foulds, Gemma A. [1 ]
Bailey, Michael D. [3 ]
Gowen-MacDonald, James [3 ]
Muth, John [8 ]
Schmitz, Marc [9 ,10 ,11 ,12 ]
Cesano, Alessandra [3 ]
Pockley, A. Graham [1 ,13 ]
Valk, Peter J. M. [14 ]
Lowenberg, Bob [14 ]
Bornhaeuser, Martin [4 ,10 ,11 ,12 ]
Tasian, Sarah K. [5 ,6 ,7 ]
Rettig, Michael P. [15 ]
Davidson-Moncada, Jan K. [8 ]
DiPersio, John F. [15 ]
Rutella, Sergio [1 ,13 ]
机构
[1] Nottingham Trent Univ, John van Geest Canc Res Ctr, Nottingham NG11 8NS, England
[2] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON M5G 2C1, Canada
[3] NanoString Technol Inc, Seattle, WA 98109 USA
[4] Univ Klinikum Carl Gustav Carus, Dept Med, D-01307 Dresden, Germany
[5] Childrens Hosp Philadelphia, Dept Pediat, Div Oncol, Philadelphia, PA 19104 USA
[6] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA
[7] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[8] MacroGenics Inc, Rockville, MD 20850 USA
[9] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Immunol, D-01307 Dresden, Germany
[10] Natl Ctr Tumor Dis NCT, Partner Site Dresden, D-01307 Dresden, Germany
[11] German Canc Consortium DKTK, Partner Site Dresden, D-69120 Heidelberg, Germany
[12] German Canc Res Ctr, D-69120 Heidelberg, Germany
[13] Nottingham Trent Univ, Ctr Hlth Ageing & Understanding Dis CHAUD, Nottingham NG11 8NS, England
[14] Erasmus MC, Dept Hematol, NL-3000 CA Rotterdam, Netherlands
[15] Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
GENE-EXPRESSION; T-CELLS; CHECKPOINT BLOCKADE; INDUCTION THERAPY; CLINICAL-OUTCOMES; SIGNATURE; RADIATION; REVEALS; PROFILE; SCORE;
D O I
10.1126/scitranslmed.aaz0463
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Acute myeloid leukemia (AML) is a molecularly and clinically heterogeneous hematological malignancy. Although immunotherapy may be an attractive modality to exploit in patients with AML, the ability to predict the groups of patients and the types of cancer that will respond to immune targeting remains limited. This study dissected the complexity of the immune architecture of AML at high resolution and assessed its influence on therapeutic response. Using 442 primary bone marrow samples from three independent cohorts of children and adults with AML, we defined immune-infiltrated and immune-depleted disease classes and revealed critical differences in immune gene expression across age groups and molecular disease subtypes. Interferon (IFN)-gamma-related mRNA profiles were predictive for both chemotherapy resistance and response of primary refractory/relapsed AML to flotetuzumab immunotherapy. Our compendium of microenvironmental gene and protein profiles provides insights into the immuno-biology of AML and could inform the delivery of personalized immunotherapies to IFN-gamma-dominant AML subtypes.
引用
收藏
页数:17
相关论文
共 74 条
[1]   IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade [J].
Ayers, Mark ;
Lunceford, Jared ;
Nebozhyn, Michael ;
Murphy, Erin ;
Loboda, Andrey ;
Kaufman, David R. ;
Albright, Andrew ;
Cheng, Jonathan D. ;
Kang, S. Peter ;
Shankaran, Veena ;
Piha-Paul, Sarina A. ;
Yearley, Jennifer ;
Seiwert, Tanguy Y. ;
Ribas, Antoni ;
McClanahan, Terrill K. .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (08) :2930-2940
[2]   Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade [J].
Benci, Joseph L. ;
Xu, Bihui ;
Qiu, Yu ;
Wu, Tony J. ;
Dada, Hannah ;
Twyman-Saint Victor, Christina ;
Cucolo, Lisa ;
Lee, David S. M. ;
Pauken, Kristen E. ;
Huang, Alexander C. ;
Gangadhar, Tara C. ;
Amaravadi, Ravi K. ;
Schuchter, Lynn M. ;
Feldman, Michael D. ;
Ishwaran, Hemant ;
Vonderheide, Robert H. ;
Maity, Amit ;
Wherry, E. John ;
Minn, Andy J. .
CELL, 2016, 167 (06) :1540-+
[3]   Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms [J].
Bezzi, Marco ;
Seitzer, Nina ;
Ishikawa, Tomoki ;
Reschke, Markus ;
Chen, Ming ;
Wang, Guocan ;
Mitchell, Caitlin ;
Ng, Christopher ;
Katon, Jesse ;
Lunardi, Andrea ;
Signoretti, Sabina ;
Clohessy, John G. ;
Zhang, Jiangwen ;
Pandolfi, Pier Paolo .
NATURE MEDICINE, 2018, 24 (02) :165-+
[4]   Understanding the tumor immune microenvironment (TIME) for effective therapy [J].
Binnewies, Mikhail ;
Roberts, Edward W. ;
Kersten, Kelly ;
Chan, Vincent ;
Fearon, Douglas F. ;
Merad, Miriam ;
Coussens, Lisa M. ;
Gabrilovich, Dmitry I. ;
Ostrand-Rosenberg, Suzanne ;
Hedrick, Catherine C. ;
Vonderheide, Robert H. ;
Pittet, Mikael J. ;
Jain, Rakesh K. ;
Zou, Weiping ;
Howcroft, T. Kevin ;
Woodhouse, Elisa C. ;
Weinberg, Robert A. ;
Krummel, Matthew F. .
NATURE MEDICINE, 2018, 24 (05) :541-550
[5]   Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma [J].
Blank, Christian U. ;
Rozeman, Elisa A. ;
Fanchi, Lorenzo F. ;
Sikorska, Karolina ;
van de Wiel, Bart ;
Kvistborg, Pia ;
Krijgsman, Oscar ;
van den Braber, Marlous ;
Philips, Daisy ;
Broeks, Annegien ;
van Thienen, Johannes, V ;
Mallo, Henk A. ;
Adriaansz, Sandra ;
ter Meulens, Sylvia ;
Pronk, Loes M. ;
Grijpink-Ongering, Lindsay G. ;
Bruining, Annemarie ;
Gittelman, Rachel M. ;
Warren, Sarah ;
van Tinteren, Harm ;
Peeper, Daniel S. ;
Haanen, John B. A. G. ;
van Akkooi, Alexander C. J. ;
Schumacher, Ton N. .
NATURE MEDICINE, 2018, 24 (11) :1655-+
[6]   The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions (vol 24, pg 103, 2017) [J].
Bolouri, Hamid ;
Farrar, Jason E. ;
Triche, Timothy, Jr. ;
Ries, Rhonda E. ;
Lim, Emilia L. ;
Alonzo, Todd A. ;
Ma, Yussanne ;
Moore, Richard ;
Mungall, Andrew J. ;
Marra, Marco A. ;
Zhang, Jinghui ;
Ma, Xiaotu ;
Liu, Yu ;
Liu, Yanling ;
Auvil, Jaime M. Guidry ;
Davidsen, Tanja M. ;
Gesuwan, Patee ;
Hermida, Leandro C. ;
Salhia, Bodour ;
Capone, Stephen ;
Ramsingh, Giridharan ;
Zwaan, Christian Michel ;
Noort, Sanne ;
Piccolo, Stephen R. ;
Kolb, E. Anders ;
Gamis, Alan S. ;
Smith, Malcolm A. ;
Gerhard, Daniela S. ;
Meshinchi, Soheil .
NATURE MEDICINE, 2018, 24 (01) :103-+
[7]   Elements of cancer immunity and the cancer-immune set point [J].
Chen, Daniel S. ;
Mellman, Ira .
NATURE, 2017, 541 (7637) :321-330
[8]   A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates [J].
Chichili, Gurunadh R. ;
Huang, Ling ;
Li, Hua ;
Burke, Steve ;
He, Leilei ;
Tang, Qin ;
Jin, Linda ;
Gorlatov, Sergey ;
Ciccarone, Valentina ;
Chen, Francine ;
Koenig, Scott ;
Shannon, Michele ;
Alderson, Ralph ;
Moore, Paul A. ;
Johnson, Syd ;
Bonvini, Ezio .
SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (289)
[9]   Immune Escape of Relapsed AML Cells after Allogeneic Transplantation [J].
Christopher, M. J. ;
Petti, A. A. ;
Rettig, M. P. ;
Miller, C. A. ;
Chendamarai, E. ;
Duncavage, E. J. ;
Klco, J. M. ;
Helton, N. M. ;
O'Laughlin, M. ;
Fronick, C. C. ;
Fulton, R. S. ;
Wilson, R. K. ;
Wartman, L. D. ;
Welch, J. S. ;
Heath, S. E. ;
Baty, J. D. ;
Payton, J. E. ;
Graubert, T. A. ;
Link, D. C. ;
Walter, M. J. ;
Westervelt, P. ;
Ley, T. J. ;
DiPersio, J. F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2330-2341
[10]   CD99 is a therapeutic target on disease stem cells in myeloid malignancies [J].
Chung, Stephen S. ;
Eng, William S. ;
Hu, Wenhuo ;
Khalaj, Mona ;
Garrett-Bakelman, Francine E. ;
Tavakkoli, Montreh ;
Levine, Ross L. ;
Carroll, Martin ;
Klimek, Virginia M. ;
Melnick, Ari M. ;
Park, Christopher Y. .
SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (374)